Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06315387
Status:
RECRUITING
Last Update Posted:
2024-03-18
First Post:
2024-03-11
Brief Title:
Safety Tolerability and Pharmacokinetics of 4-MUST Tablets 128 mg Valenta Pharm JSC During Single and Multiple Oral Administration in Healthy Volunteers
Sponsor:
Valenta Pharm JSC
Organization:
Valenta Pharm JSC
Study Overview
Official Title:
Open Study of Safety Tolerability and Pharmacokinetic Parameters of Increasing Doses of 4-MUST Tablets 128 mg Valenta Pharm JSC During Single and Subsequent Multiple Oral Administration in Healthy Volunteers
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study of safety tolerability and pharmacokinetic parameters of different doses of 4-MUST tablets 128 mg Valenta Pharm JSC in healthy volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None